3 Dow Movers with News You Must Know

McDonald’s Corp. (NYSE:MCD) affirms a report in China Daily that says it increased the four different products by 1 yuan (around 15 cents), at the end of April, marking the second price bump so far this year.

Don’t Miss: Will Amazon’s New Product Line Better Compete With Apple?

Merck & Co. Inc. (NYSE:MRK) is one of seven firms which have signed confidentiality agreements as part of Amylin’s (NASDAQ:AMLN) acquisition process, says a Bloomberg report that cites unnamed sources. The latter’s shares are jumping, as the firm is courted by Pfizer (NYSE:PFE), AstraZeneca (NYSE:AZN), Sanofi (NYSE:SNY), Bristol-Myers (NYSE:BMY), Roche (RHHBY), Takeda, and Merck. First-round offers for the company are to be received inside the next two weeks. Leerink Swank, in a letter to investors, notes that Amylin should go for a bid in the low $30 range, but a mid-$30s offer is not out of the question and that a bidding war could push that range up. Leerink says that an Amylin purchase would make sense strategically for all seven suitors, but that Sanofi and Merck would benefit the most. The analyst retains its Outperform rating on Amylin.

Microsoft Corporation (NASDAQ:MSFT), Facebook (FB), Google (NASDAQ:GOOG) and F5 Networks (NASDAQ:FFIV) will have to compete for suitable talent in the Seattle area, as they expand in the region, and also due to Amazon.com’s (NASDAQ:AMZN) plans to hire more than 1,000 new tech employees for its office in the city, says TechFlash.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

Don’t Miss: ESPN Makes a Play For Apple.